Cite
Freemantle N, Cooper C, Roux C, et al. Baseline observations from the POSSIBLE EU® study: characteristics of postmenopausal women receiving bone loss medications. Arch Osteoporos. 2010;5(1):61-72doi: 10.1007/s11657-010-0035-7.
Freemantle, N., Cooper, C., Roux, C., Díez-Pérez, A., Guillemin, F., Jonsson, B., Ortolani, S., Pfeilschifter, J., Horne, R., Kakad, S., Shepherd, S., Möller, G., Marciniak, A., & Martinez, L. (2010). Baseline observations from the POSSIBLE EU® study: characteristics of postmenopausal women receiving bone loss medications. Archives of osteoporosis, 5(1), 61-72. https://doi.org/10.1007/s11657-010-0035-7
Freemantle, Nick, et al. "Baseline observations from the POSSIBLE EU® study: characteristics of postmenopausal women receiving bone loss medications." Archives of osteoporosis vol. 5,1 (2010): 61-72. doi: https://doi.org/10.1007/s11657-010-0035-7
Freemantle N, Cooper C, Roux C, Díez-Pérez A, Guillemin F, Jonsson B, Ortolani S, Pfeilschifter J, Horne R, Kakad S, Shepherd S, Möller G, Marciniak A, Martinez L. Baseline observations from the POSSIBLE EU® study: characteristics of postmenopausal women receiving bone loss medications. Arch Osteoporos. 2010 Dec;5(1):61-72. doi: 10.1007/s11657-010-0035-7. Epub 2010 Feb 27. PMID: 21258637; PMCID: PMC3010211.
Copy
Download .nbib